Response rate as an endpoint in clinical trials

J Natl Cancer Inst. 2007 Jan 17;99(2):98-9. doi: 10.1093/jnci/djk024.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Bone Neoplasms / drug therapy
  • Bone Neoplasms / mortality
  • Bone Neoplasms / pathology*
  • Clinical Trials, Phase III as Topic
  • Disease-Free Survival
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Europe / epidemiology
  • Humans
  • Multicenter Studies as Topic
  • Osteosarcoma / drug therapy
  • Osteosarcoma / mortality
  • Osteosarcoma / pathology*
  • Randomized Controlled Trials as Topic
  • Treatment Outcome